Journal article

Genetic modifiers of CHEK2∗1100delC-associated breast cancer risk

TA Muranen, D Greco, C Blomqvist, K Aittomäki, S Khan, F Hogervorst, S Verhoef, PDP Pharoah, AM Dunning, M Shah, R Luben, SE Bojesen, BG Nordestgaard, M Schoemaker, A Swerdlow, M García-Closas, J Figueroa, T Dörk, NV Bogdanova, P Hall Show all

Genetics in Medicine | NATURE PUBLISHING GROUP | Published : 2017

Abstract

Purpose:CHEK2∗1100delC is a founder variant in European populations that confers a two- to threefold increased risk of breast cancer (BC). Epidemiologic and family studies have suggested that the risk associated with CHEK2∗1100delC is modified by other genetic factors in a multiplicative fashion. We have investigated this empirically using data from the Breast Cancer Association Consortium (BCAC).Methods:Using genotype data from 39,139 (624 1100delC carriers) BC patients and 40,063 (224) healthy controls from 32 BCAC studies, we analyzed the combined risk effects of CHEK2∗1100delC and 77 common variants in terms of a polygenic risk score (PRS) and pairwise interaction.Results:The PRS conferr..

View full abstract